A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

EQS-News: SynBiotic SE / Key word (s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this ...

Thailand Pharmaceutical Industry, according to Fitch Solutions, the pharmaceutical market in Southeast Asia has a market size ...

Lakeside Holding (LSH) is pleased to announce that through its wholly-owned subsidiary, Sichuan Hupan Jincheng Enterprise Management Co., has ...

Scott Power had his eyes on Sigma Healthcare this week, which soared after the ACCC approves its merger with Chemist ...

Two of Australia's biggest pharmacy brands are joining forces to become a multi-billion-dollar pharmaceutical juggernaut. Here's why the competition watchdog gave the deal the all-clear.

The unnamed big pharma buyer evidently has decided that a US$150 million ... The union will combine Sigma’s 400-plus Amcal ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

As of fiscal year-end 2024, McKesson had a cash and cash equivalents balance of $4.6 billion with an outstanding debt balance of $5.6 billion. Roughly one third of its debt is due to mature over the ...

Egypt’s Suez Canal Economic Zone (SCZONE) unveiled on Monday plans for a vast 4-million-square-metre (sqm) pharmaceutical industrial zone to attract medicine and medical device manufacturers, aligning ...